免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

M-2018-334 in Hematological Malignancies

NCT:NCT06225050 · RECRUITING

NCT IDNCT06225050
狀態RECRUITING
開始日期2026-08-21
完成時間2029-02-28
SponsorMiltenyi Biomedicine GmbH (INDUSTRY)
First posted
Last updated

簡要摘要

This is a single-center, open-label, single-arm, pilot clinical study using TCRα/β and CD45RA depleted stem cell grafts from haploidentical donors for hematopoietic cell transplantation in 12 to 18 adult patients.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑